111 related articles for article (PubMed ID: 36332446)
21. The Prognostic Significance of APOBEC3B and PD-L1/PD-1 in Nasopharyngeal Carcinoma.
Feng C; Zhang Y; Huang J; Zheng Q; Yang Y; Xu B
Appl Immunohistochem Mol Morphol; 2021 Mar; 29(3):239-244. PubMed ID: 32205739
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of PD-L1 and Siglec-15 expression in patients with nasopharyngeal carcinoma.
Zhao J; Yang H; Hu H; Liu C; Wei M; Zhao Y; Chen Y; Cui Y; Chen P; Xiong K; Lu Y; Yang H; Yang L
Sci Rep; 2022 Jun; 12(1):10401. PubMed ID: 35729260
[TBL] [Abstract][Full Text] [Related]
23. Exome Sequencing Identifies Potentially Druggable Mutations in Nasopharyngeal Carcinoma.
Chow YP; Tan LP; Chai SJ; Abdul Aziz N; Choo SW; Lim PV; Pathmanathan R; Mohd Kornain NK; Lum CL; Pua KC; Yap YY; Tan TY; Teo SH; Khoo AS; Patel V
Sci Rep; 2017 Mar; 7():42980. PubMed ID: 28256603
[TBL] [Abstract][Full Text] [Related]
24. Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma.
Zheng H; Dai W; Cheung AK; Ko JM; Kan R; Wong BW; Leong MM; Deng M; Kwok TC; Chan JY; Kwong DL; Lee AW; Ng WT; Ngan RK; Yau CC; Tung S; Lee VH; Lam KO; Kwan CK; Li WS; Yau S; Chan KW; Lung ML
Proc Natl Acad Sci U S A; 2016 Oct; 113(40):11283-11288. PubMed ID: 27647909
[TBL] [Abstract][Full Text] [Related]
25. Genetic and epigenetic landscape of nasopharyngeal carcinoma.
Dai W; Zheng H; Cheung AK; Lung ML
Chin Clin Oncol; 2016 Apr; 5(2):16. PubMed ID: 27121876
[TBL] [Abstract][Full Text] [Related]
26. Identification of genomic alterations in nasopharyngeal carcinoma and nasopharyngeal carcinoma-derived Epstein-Barr virus by whole-genome sequencing.
Tu C; Zeng Z; Qi P; Li X; Guo C; Xiong F; Xiang B; Zhou M; Liao Q; Yu J; Li Y; Li X; Li G; Xiong W
Carcinogenesis; 2018 Dec; 39(12):1517-1528. PubMed ID: 30102338
[TBL] [Abstract][Full Text] [Related]
27. Characterization of PD-L1 expression and immune cell infiltration in nasopharyngeal cancer.
Chan OS; Kowanetz M; Ng WT; Koeppen H; Chan LK; Yeung RM; Wu H; Amler L; Mancao C
Oral Oncol; 2017 Apr; 67():52-60. PubMed ID: 28351581
[TBL] [Abstract][Full Text] [Related]
28. The genomic landscape of nasopharyngeal carcinoma.
Lin DC; Meng X; Hazawa M; Nagata Y; Varela AM; Xu L; Sato Y; Liu LZ; Ding LW; Sharma A; Goh BC; Lee SC; Petersson BF; Yu FG; Macary P; Oo MZ; Ha CS; Yang H; Ogawa S; Loh KS; Koeffler HP
Nat Genet; 2014 Aug; 46(8):866-71. PubMed ID: 24952746
[TBL] [Abstract][Full Text] [Related]
29. Whole-tumor-antigen-pulsed dendritic cells elicit cytotoxic T-cell response against pediatric nasopharyngeal carcinoma in vitro.
Yufeng D; Guocheng Z; Dongliang X; Rong F; Yuhong C; Ruying L; Jingshi Z; Xuhong Z
Med Oncol; 2009; 26(1):78-85. PubMed ID: 18810669
[TBL] [Abstract][Full Text] [Related]
30. PD-1 and PD-L1 in locoregionally advanced nasopharyngeal carcinoma: Substudy of a randomized phase III trial.
Cao C; Wei Q; Tang X; Jia Y; Sun X; Li W; Hu Q; Chen X
Head Neck; 2019 May; 41(5):1427-1433. PubMed ID: 30582240
[TBL] [Abstract][Full Text] [Related]
31. MircoRNA-629 promotes proliferation, invasion and migration of nasopharyngeal carcinoma through targeting PDCD4.
Zheng YQ; Bai YF; Yang S; Cui YR; Wang YP; Hu WL
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):207-216. PubMed ID: 30657562
[TBL] [Abstract][Full Text] [Related]
32. Expression of Immune Checkpoint Regulators, Cytotoxic T-Lymphocyte Antigen-4, and Programmed Death-Ligand 1 in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma.
Ahmed MM; Gebriel MG; Morad EA; Saber IM; Elwan A; Salah M; Fakhr AE; Shalaby AM; Alabiad MA
Appl Immunohistochem Mol Morphol; 2021 Jul; 29(6):401-408. PubMed ID: 33480605
[TBL] [Abstract][Full Text] [Related]
33. Co-expression of PD-1 and PD-L1 predicts poor outcome in nasopharyngeal carcinoma.
Zhang J; Fang W; Qin T; Yang Y; Hong S; Liang W; Ma Y; Zhao H; Huang Y; Xue C; Huang P; Hu Z; Zhao Y; Zhang L
Med Oncol; 2015 Mar; 32(3):86. PubMed ID: 25702326
[TBL] [Abstract][Full Text] [Related]
34. Clinical trial data of Anti-PD-1/PD-L1 therapy for recurrent or metastatic nasopharyngeal Carcinoma: A review.
Adkins DR; Haddad RI
Cancer Treat Rev; 2022 Sep; 109():102428. PubMed ID: 35753157
[TBL] [Abstract][Full Text] [Related]
35. Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma.
Lee VH; Lo AW; Leung CY; Shek WH; Kwong DL; Lam KO; Tong CC; Sze CK; Leung TW
PLoS One; 2016; 11(6):e0157969. PubMed ID: 27341634
[TBL] [Abstract][Full Text] [Related]
36. Whole exome sequencing identifies the potential role of genes involved in p53 pathway in Nasopharyngeal Carcinoma from Northeast India.
Laskar S; Das R; Kundu S; Saha A; Nandi N; Choudhury Y; Kumar Ghosh S
Gene; 2022 Feb; 812():146099. PubMed ID: 34906645
[TBL] [Abstract][Full Text] [Related]
37. Dissecting the heterogeneity of the microenvironment in primary and recurrent nasopharyngeal carcinomas using single-cell RNA sequencing.
Peng WS; Zhou X; Yan WB; Li YJ; Du CR; Wang XS; Shen CY; Wang QF; Ying HM; Lu XG; Xu TT; Hu CS
Oncoimmunology; 2022; 11(1):2026583. PubMed ID: 35096485
[TBL] [Abstract][Full Text] [Related]
38. Genomic scoring to determine clinical benefit of immunotherapy by targeted sequencing.
Kim HS; Cha H; Kim J; Park WY; Choi YL; Sun JM; Ahn JS; Ahn MJ; Park K; Lee SH
Eur J Cancer; 2019 Oct; 120():65-74. PubMed ID: 31493723
[TBL] [Abstract][Full Text] [Related]
39. ΔNp63α is a super enhancer-enriched master factor controlling the basal-to-luminal differentiation transcriptional program and gene regulatory networks in nasopharyngeal carcinoma.
Cai J; Chen S; Yi M; Tan Y; Peng Q; Ban Y; Yang J; Li X; Zeng Z; Xiong W; McCarthy JB; Li G; Li X; Xiang B
Carcinogenesis; 2020 Sep; 41(9):1282-1293. PubMed ID: 31826234
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA NPCCAT1 promotes nasopharyngeal carcinoma progression via upregulating YY1.
Su H; Liu L; Zhang Y; Wang J; Zhao Y
Biochimie; 2019 Feb; 157():184-194. PubMed ID: 30481541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
